Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 218 | $182,336,147 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
10 Jan 2024 16:31 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | 08 Jan 2024 | Sale | 105,835 | 132.4375 | 14,016,523 | D |
15 Mar 2024 17:33 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 14 Mar 2024 | Sale | 69,521 | 139.3789 | 9,689,761 | D |
04 Jan 2024 18:32 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Business Development Off | 02 Jan 2024 | Sale | 68,884 | 131.4716 | 9,056,290 | D |
10 Jan 2024 16:31 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | 09 Jan 2024 | Sale | 62,023 | 134.0131 | 8,311,895 | D |
29 Feb 2024 18:55 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 28 Feb 2024 | Sale | 53,143 | 134.6881 | 7,157,730 | D |
11 Dec 2023 18:18 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 07 Dec 2023 | Sale | 38,722 | 120.3739 | 4,661,118 | D |
30 May 2024 16:38 | NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Director | 29 May 2024 | Sale | 25,000 | 133.4622 | 3,336,555 | D |
15 Mar 2024 17:19 | NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Director | 13 Mar 2024 | Sale | 23,200 | 140.3285 | 3,255,621 | D |
10 Nov 2022 17:50 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 08 Nov 2022 | Sale | 24,593 | 125.3332 | 3,082,319 | D |
29 Feb 2024 18:55 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 28 Feb 2024 | Sale | 21,857 | 134.6881 | 2,943,878 | D |
01 Dec 2022 18:43 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 30 Nov 2022 | Sale | 22,162 | 125.9017 | 2,790,233 | D |
15 Mar 2024 17:25 | NBIX | NEUROCRINE BIOSCIENCES INC | MORROW GEORGE J | Director | 14 Mar 2024 | Sale | 20,000 | 139.4216 | 2,788,432 | D |
15 Mar 2024 17:25 | NBIX | NEUROCRINE BIOSCIENCES INC | MORROW GEORGE J | Director | 14 Mar 2024 | Sale | 20,000 | 139.4139 | 2,788,278 | D |
01 Dec 2022 18:43 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 30 Nov 2022 | Sale | 20,063 | 125.9017 | 2,525,966 | D |
08 Dec 2023 18:23 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 06 Dec 2023 | Sale | 20,830 | 119.8583 | 2,496,648 | D |
15 Aug 2024 17:12 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 13 Aug 2024 | Sale | 14,100 | 150.3792 | 2,120,347 | D |
16 May 2024 16:40 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 15 May 2024 | Sale | 15,000 | 140.2406 | 2,103,609 | D |
08 Feb 2023 19:28 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | 07 Feb 2023 | Sale | 20,482 | 102.4338 | 2,098,049 | D |
16 Aug 2024 17:00 | NBIX | NEUROCRINE BIOSCIENCES INC | RASTETTER WILLIAM H | Director | 15 Aug 2024 | Sale | 14,250 | 146.69 | 2,090,332 | D |
16 May 2024 16:40 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 14 May 2024 | Sale | 15,000 | 135.6551 | 2,034,826 | D |
30 May 2024 16:38 | NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Director | 29 May 2024 | Sale | 15,000 | 133.4673 | 2,002,010 | D |
22 Feb 2024 17:11 | NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Director | 20 Feb 2024 | Sale | 15,000 | 132.4698 | 1,987,047 | D |
05 Aug 2024 17:40 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 01 Aug 2024 | Sale | 12,632 | 153.2629 | 1,936,017 | D |
27 Dec 2023 16:08 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 22 Dec 2023 | Sale | 14,000 | 129.9902 | 1,819,863 | D |
05 Jan 2023 18:18 | NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Director | 03 Jan 2023 | Sale | 15,000 | 119.203 | 1,788,045 | D |
05 Jan 2023 18:21 | NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Director | 03 Jan 2023 | Sale | 15,000 | 118.8651 | 1,782,976 | D |
05 Jan 2023 18:21 | NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Director | 03 Jan 2023 | Sale | 15,000 | 118.8501 | 1,782,752 | D |
15 Aug 2024 17:21 | NBIX | NEUROCRINE BIOSCIENCES INC | LYONS GARY A | Director | 13 Aug 2024 | Sale | 11,570 | 150.4278 | 1,740,450 | D |
02 Nov 2022 18:42 | NBIX | NEUROCRINE BIOSCIENCES INC | LYONS GARY A | Director | 31 Oct 2022 | Sale | 15,000 | 114.7602 | 1,721,403 | D |
11 Dec 2023 18:18 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 07 Dec 2023 | Sale | 14,140 | 120.3715 | 1,702,053 | D |
16 May 2024 16:55 | NBIX | NEUROCRINE BIOSCIENCES INC | LYONS GARY A | Director | 14 May 2024 | Sale | 12,500 | 135.6296 | 1,695,370 | D |
17 Apr 2024 17:19 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 15 Apr 2024 | Sale | 12,587 | 133.3646 | 1,678,660 | D |
08 Feb 2023 19:18 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 07 Feb 2023 | Sale | 15,360 | 102.4235 | 1,573,225 | D |
11 Dec 2023 18:18 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 07 Dec 2023 | Sale | 12,742 | 120.3715 | 1,533,774 | D |
26 Apr 2023 21:22 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 24 Apr 2023 | Sale | 14,400 | 103.4763 | 1,490,059 | D |
04 Jan 2024 18:26 | NBIX | NEUROCRINE BIOSCIENCES INC | RASTETTER WILLIAM H | Director | 02 Jan 2024 | Sale | 11,044 | 131.4675 | 1,451,927 | D |
11 Dec 2023 18:18 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 07 Dec 2023 | Sale | 11,775 | 120.3715 | 1,417,374 | D |
02 Jul 2024 21:36 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 01 Jul 2024 | Sale | 10,000 | 140.1864 | 1,401,864 | D |
24 Jan 2024 17:47 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 22 Jan 2024 | Sale | 10,000 | 139.8553 | 1,398,553 | D |
08 Feb 2023 19:16 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 07 Feb 2023 | Sale | 12,807 | 102.4196 | 1,311,688 | D |
08 Feb 2023 19:32 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 07 Feb 2023 | Sale | 12,801 | 102.4191 | 1,311,067 | D |
08 Feb 2023 19:22 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 07 Feb 2023 | Sale | 12,801 | 102.4127 | 1,310,985 | D |
08 Feb 2023 19:25 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Business Development Off | 07 Feb 2023 | Sale | 12,801 | 102.4114 | 1,310,968 | D |
08 Feb 2023 19:35 | NBIX | NEUROCRINE BIOSCIENCES INC | LLOYD-SMITH MALCOLM | Chief Integration Officer | 07 Feb 2023 | Sale | 12,801 | 102.4108 | 1,310,961 | D |
08 Feb 2023 19:40 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 07 Feb 2023 | Sale | 12,801 | 102.4075 | 1,310,918 | D |
08 Feb 2023 19:56 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 07 Feb 2023 | Sale | 12,801 | 102.4073 | 1,310,916 | D |
27 Dec 2023 16:10 | NBIX | NEUROCRINE BIOSCIENCES INC | LYONS GARY A | Director | 22 Dec 2023 | Sale | 10,000 | 130.0443 | 1,300,443 | D |
27 Dec 2023 16:08 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 22 Dec 2023 | Sale | 10,000 | 126.7945 | 1,267,945 | D |
27 Dec 2023 16:15 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 22 Dec 2023 | Sale | 10,000 | 126.7448 | 1,267,448 | D |
29 Nov 2023 16:36 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 27 Nov 2023 | Sale | 10,919 | 112.2732 | 1,225,911 | D |
02 Nov 2022 18:33 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 01 Nov 2022 | Sale | 10,000 | 120.0899 | 1,200,899 | D |
03 May 2023 17:28 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 01 May 2023 | Sale | 11,397 | 103.8913 | 1,184,049 | D |
08 Feb 2023 19:22 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 07 Feb 2023 | Sale | 11,497 | 102.421 | 1,177,534 | D |
08 Feb 2023 19:16 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 07 Feb 2023 | Sale | 11,491 | 102.4013 | 1,176,693 | D |
04 Nov 2022 16:56 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 03 Nov 2022 | Sale | 8,968 | 125.0204 | 1,121,183 | D |
05 Oct 2022 18:33 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 04 Oct 2022 | Sale | 10,000 | 111.0446 | 1,110,446 | D |
29 Feb 2024 18:50 | NBIX | NEUROCRINE BIOSCIENCES INC | NORWALK LESLIE V | Director | 27 Feb 2024 | Sale | 8,000 | 135.6735 | 1,085,388 | D |
18 Jul 2024 16:41 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 16 Jul 2024 | Sale | 7,004 | 149.9986 | 1,050,590 | D |
08 Dec 2023 19:09 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 06 Dec 2023 | Sale | 8,396 | 120.031 | 1,007,780 | D |
23 Aug 2023 20:08 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | 21 Aug 2023 | Sale | 9,328 | 107.3988 | 1,001,816 | D |
01 Dec 2022 18:43 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 30 Nov 2022 | Sale | 7,775 | 125.9017 | 978,886 | D |
17 Apr 2024 17:19 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 15 Apr 2024 | Sale | 7,231 | 133.3646 | 964,359 | D |
04 Nov 2022 17:02 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 03 Nov 2022 | Sale | 7,264 | 125.0047 | 908,034 | D |
14 Dec 2023 17:22 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 12 Dec 2023 | Sale | 6,978 | 120.3011 | 839,461 | D |
14 Dec 2023 17:22 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 12 Dec 2023 | Sale | 6,947 | 120.3079 | 835,779 | D |
04 Jan 2024 18:32 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Business Development Off | 02 Jan 2024 | Sale | 6,116 | 131.4429 | 803,905 | D |
15 Mar 2024 17:33 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 14 Mar 2024 | Sale | 5,479 | 139.3789 | 763,657 | D |
25 Mar 2024 18:02 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 21 Mar 2024 | Sale | 5,000 | 145.064 | 725,320 | D |
10 Nov 2022 17:47 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 08 Nov 2022 | Sale | 5,592 | 124.9909 | 698,949 | D |
10 Nov 2022 17:48 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 08 Nov 2022 | Sale | 5,082 | 125.0377 | 635,442 | D |
21 Apr 2023 18:58 | NBIX | NEUROCRINE BIOSCIENCES INC | RASTETTER WILLIAM H | Director | 21 Apr 2023 | Sale | 6,034 | 105.0359 | 633,787 | D |
15 Aug 2024 17:06 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 13 Aug 2024 | Sale | 4,100 | 150.0813 | 615,333 | D |
28 Oct 2022 17:45 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 26 Oct 2022 | Sale | 5,077 | 115.0218 | 583,966 | D |
05 Dec 2023 16:54 | NBIX | NEUROCRINE BIOSCIENCES INC | LYONS GARY A | Director | 01 Dec 2023 | Sale | 5,000 | 116.7674 | 583,837 | D |
14 Sep 2023 16:51 | NBIX | NEUROCRINE BIOSCIENCES INC | LYONS GARY A | Director | 12 Sep 2023 | Sale | 5,000 | 115.024 | 575,120 | D |
28 Oct 2022 17:45 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 27 Oct 2022 | Sale | 4,923 | 115.0379 | 566,332 | D |
04 Nov 2022 17:51 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 03 Nov 2022 | Sale | 4,518 | 125.0224 | 564,851 | D |
05 Oct 2022 19:00 | NBIX | NEUROCRINE BIOSCIENCES INC | LYONS GARY A | Director | 04 Oct 2022 | Sale | 5,000 | 110.5422 | 552,711 | D |
06 Sep 2023 16:25 | NBIX | NEUROCRINE BIOSCIENCES INC | LYONS GARY A | Director | 01 Sep 2023 | Sale | 5,000 | 110.0631 | 550,316 | D |
19 Oct 2022 17:55 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 17 Oct 2022 | Sale | 4,960 | 110.8229 | 549,682 | D |
05 Aug 2024 17:18 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 01 Aug 2024 | Sale | 2,996 | 154.013 | 461,423 | D |
08 Feb 2023 19:38 | NBIX | NEUROCRINE BIOSCIENCES INC | ONYIA JUDE | Chief Scientific Officer | 07 Feb 2023 | Sale | 4,508 | 102.2995 | 461,166 | D |
15 Aug 2024 17:06 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 13 Aug 2024 | Sale | 3,043 | 150.1305 | 456,847 | D |
03 May 2023 17:34 | NBIX | NEUROCRINE BIOSCIENCES INC | RASTETTER WILLIAM H | Director | 01 May 2023 | Sale | 4,300 | 101.4268 | 436,135 | D |
08 Feb 2024 19:21 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | 06 Feb 2024 | Sale | 3,040 | 142.1771 | 432,218 | D |
17 Sep 2024 16:21 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 13 Sep 2024 | Sale | 3,461 | 121.8804 | 421,828 | D |
15 Mar 2024 17:15 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 13 Mar 2024 | Sale | 3,000 | 140.1398 | 420,419 | D |
02 Feb 2024 19:21 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | 31 Jan 2024 | Sale | 2,707 | 140.6888 | 380,845 | D |
15 Feb 2024 17:43 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | 13 Feb 2024 | Sale | 2,832 | 133.0157 | 376,700 | D |
23 Aug 2023 20:20 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 21 Aug 2023 | Sale | 3,198 | 107.3758 | 343,388 | D |
23 Aug 2023 20:10 | NBIX | NEUROCRINE BIOSCIENCES INC | ONYIA JUDE | Chief Scientific Officer | 21 Aug 2023 | Sale | 3,198 | 107.3696 | 343,368 | D |
29 Feb 2024 19:02 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 28 Feb 2024 | Sale | 2,500 | 135.6414 | 339,104 | D |
29 Feb 2024 19:02 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 28 Feb 2024 | Sale | 2,500 | 134.62 | 336,550 | D |
08 Feb 2023 19:28 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | 07 Feb 2023 | Sale | 3,248 | 102.2985 | 332,266 | D |
08 Feb 2023 19:28 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | 06 Feb 2023 | Sale | 3,040 | 105.6772 | 321,259 | D |
08 Feb 2024 19:21 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | 08 Feb 2024 | Sale | 2,274 | 134.1479 | 305,052 | D |
02 Feb 2023 17:19 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | 31 Jan 2023 | Sale | 2,707 | 110.0839 | 297,997 | D |
21 May 2024 17:27 | NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Director | 17 May 2024 | Sale | 2,100 | 141.8383 | 297,860 | D |
01 Dec 2022 18:35 | NBIX | NEUROCRINE BIOSCIENCES INC | ONYIA JUDE | Chief Scientific Officer | 29 Nov 2022 | Sale | 2,331 | 121.9048 | 284,160 | D |
01 Dec 2023 17:41 | NBIX | NEUROCRINE BIOSCIENCES INC | ONYIA JUDE | Chief Scientific Officer | 29 Nov 2023 | Sale | 2,331 | 113.5705 | 264,733 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)